Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study

I'm interested

30 Months to 72 Months old
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• Ages 2.5 years to 5 years old (<6 years of age) at enrollment
• Prenatal alcohol exposure
• Available parent or legal guardian capable of giving informed consent for participation.
Exclusion Criteria:

• History of a neurological condition (ex. epilepsy, traumatic brain injury)
• History of a medical condition known to affect brain function
• Other neurodevelopmental disorder (ex. autism, Down syndrome)
• History of very low birthweight (<1500 grams)

Drug: Choline Bitartrate

Fetal Alcohol Spectrum Disorders

Jeffrey R Wozniak, Ph.D. -
Michael K Georgieff, M.D. -
Phase 2
See this study on